- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
18
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
18 companies
Madrigal Pharmaceuticals
Market Cap: US$10.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$444.83
7D
2.8%
1Y
27.7%
Ascendis Pharma
Market Cap: US$14.1b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$225.98
7D
-6.1%
1Y
47.7%
Insmed
Market Cap: US$30.1b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$139.50
7D
-0.4%
1Y
82.2%
Alnylam Pharmaceuticals
Market Cap: US$42.1b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$313.41
7D
-2.3%
1Y
29.6%
BridgeBio Pharma
Market Cap: US$13.2b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$69.41
7D
6.2%
1Y
110.5%
Summit Therapeutics
Market Cap: US$12.0b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
SMMT
US$16.12
7D
6.7%
1Y
-22.5%
BeOne Medicines
Market Cap: US$31.6b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$284.05
7D
-5.7%
1Y
9.6%
Ionis Pharmaceuticals
Market Cap: US$11.9b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$71.19
7D
-3.8%
1Y
116.0%
AbbVie
Market Cap: US$398.5b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$219.68
7D
-4.5%
1Y
3.7%
Jazz Pharmaceuticals
Market Cap: US$11.1b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$178.55
7D
-1.9%
1Y
29.4%
Eli Lilly
Market Cap: US$873.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$985.08
7D
-0.5%
1Y
21.1%
BioMarin Pharmaceutical
Market Cap: US$11.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$58.51
7D
-4.3%
1Y
-15.7%
Natera
Market Cap: US$27.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$187.85
7D
-5.2%
1Y
26.7%
Royalty Pharma
Market Cap: US$26.5b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$45.65
7D
0.5%
1Y
39.3%
Viatris
Market Cap: US$15.9b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.51
7D
-4.6%
1Y
48.5%
Exact Sciences
Market Cap: US$19.7b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$103.57
7D
0.07%
1Y
130.2%
Elanco Animal Health
Market Cap: US$11.3b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.94
7D
-1.8%
1Y
119.7%
Waters
Market Cap: US$27.8b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$286.57
7D
-5.3%
1Y
-24.0%